Renal: Renal Transitional Cell Carcinoma: Free MSRA Podcast

✅ MSRA Deep Dive: Renal Transitional Cell Carcinoma (TCC)In this episode, we dissect Renal Transitional Cell Carcinoma (TCC) — a rare but important urinary tract cancer — using high-yield MSRA revision notes. Whether you're revising for exams or consolidating your urology knowledge, this focused session helps you understand what it is, why it matters, and how to manage it effectively.🧠 Key Learning Points📌 Definition• Renal TCC is a cancer originating from the transitional (urothelial) epithelium lining the renal pelvis and ureter• Accounts for only ~5% of all kidney malignancies• Shares histology with bladder TCC, same epithelial origin📌 Causes & Risk Factors• Smoking – top risk factor• Occupational exposures – aromatic amines in dyes, rubber, plastics, coal, asphalt• Chronic urinary tract inflammation• Lynch syndrome – genetic predisposition• Previous pelvic radiation🔍 Key mechanism: carcinogens excreted in urine → prolonged contact with transitional lining → DNA damage📌 Pathophysiology• Initiated in transitional epithelium• Driven by mutations in TP53 and FGFR3 genes• Loss of normal cell cycle control → dysplasia → invasive cancer• Can arise de novo or as recurrence/metastasis from lower tract (e.g. bladder)📌 Epidemiology• Rare – ~5% of kidney cancers• Incidence varies globally – always consult UK-specific data where applicable📌 Clinical Features• Most common = painless gross haematuria (seen in 75–95%)• Other signs: flank pain, recurrent UTIs, palpable mass• Triad (haematuria, pain, mass) = only 15%• Late signs: bone pain, weight loss, haemoptysis (lung mets), fatigue📌 Differential Diagnosis• Renal cell carcinoma (RCC) – more common kidney cancer• Bladder or ureteric TCC• Stones, UTIs, benign strictures, other renal masses📌 Diagnosis & Investigations• Initial: FBC, U&Es, urine microscopy & culture• Urine cytology – screens for malignant cells• Ureteroscopy with biopsy – gold standard for diagnosis• CT urogram – key for staging and differentiating from stones• Further imaging: CT chest/abdomen/pelvis, bone scan, PET-CT if metastasis suspected• Staging: TNM system – vital for treatment decisions📌 Management🔹 Localised disease• Surgery = mainstaySegmental ureterectomy or partial nephrectomy (small, low-grade)Radical nephroureterectomy = standard for high-grade/multifocal• Endoscopic resection for superficial tumours🔹 Systemic/Advanced disease• Chemotherapy – e.g. MVAC (methotrexate, vinblastine, doxorubicin, cisplatin) or Gem/Cis• Immunotherapy – e.g. pembrolizumab for metastatic/refractory cases• Intrarenal therapies (via nephrostomy): mitomycin C or BCG in selected cases• Radiotherapy – palliative or where surgery unsuitable🔹 Follow-up• Based on grade and stage• Regular: imaging, cytology, cystoscopy📌 Prognosis• Highly stage-dependentTIS/TA/T1 = 91% 5-year survivalT2 (muscle invasion) = 43%T3/T4/N1/N2 = 23%N3/M1 = 0%🔑 Key revision point: early-stage = excellent outlook, metastatic = very poor prognosis📌 Complications• Local invasion of surrounding tissue• Distant metastases – lungs, liver, bone• Loss of renal function (from tumour or nephrectomy)• Treatment side effects – chemo toxicity, surgical risks📚 Resources for MSRA Revision📄 Revision Notes:https://www.passthemsra.com/topic/renal-transitional-cell-carcinoma-revision-notes/💬 Flashcards:https://www.passthemsra.com/topic/renal-transitional-cell-carcinoma-flashcards/🧠 Accordion Q&A Notes:https://www.passthemsra.com/topic/renal-transitional-cell-carcinoma-accordion-qa-notes/📝 Rapid Quiz:https://www.passthemsra.com/topic/renal-transitional-cell-carcinoma-rapid-quiz/📘 Renal Course:https://www.passthemsra.com/courses/renal-for-the-msra/🏷️ Hashtags#MSRA #MSRARevision #RenalTCC #TransitionalCellCarcinoma #RenalCancer #KidneyCancer #Haematuria #Urology #PassTheMSRA #FreeMSRA #MSRAFlashcards #MSRAQuiz #MSRANotes